Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
TGF-beta: a master immune regulator
HTML
Details
Locations
Year:
2020
Type:
review
Source:
Expert Opinion on Therapeutic Targets
DOI:
10.1080/14728222.2020.1744568
Authors:
Christopher Larson,
Bryan Oronsky,
Corey A. Carter,
Arnold Oronsky,
Susan J. Knox,
David Sher,
Tony R. Reid
show all 7
Institutions:
EpicentRx, Inc. (United States),
Stanford Medicine,
Stanford University,
The University of Texas Southwestern Medical Center,
University of California San Diego
Language:
English
Topic:
TGF-β signaling in diseases
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
TGF-beta,
cancer immunotherapy,
immune checkpoint,
tumor microenvironment,
T cell tolerance,
immunosuppression,
cold tumors,
predictive biomarkers,
PD-1,
PD-L1,
microsatellite instability,
tumor mutational burden,
immunotherapy response prediction
show all 13
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W3012963315
FWCI:
2.306
Cites:
123
Cited by:
238
Related to:
9